EXPLORE CONNECTIONS
Using a recently approved tumor mutational burden biomarker to stratify patients for immunotherapy may introduce a sex bias
Follow the relationships that help you find your next source.
Connections are not prepared for this record yet, or its source metadata has changed. The original record remains available while background snapshots are rebuilt.